In Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis Report By Product (Instrument, Reagent, Service), By Technology (Clinical Chemistry, Molecular Diagnostics, Microbiology), And Segment Forecasts, 2018 - 2025

  • ID: 4582041
  • Report
  • Region: Global
  • 159 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMerieux
  • Cepheid
  • Danaher
  • Hologic, Inc. (Gen Probe)
  • Qiagen N.V.
  • MORE

The global in vitro diagnostics (IVD) market size is expected to reach USD 98.99 billion by 2025. It is anticipated to expand at a CAGR of 6.6% over the forecast period. Increasing geriatric population, which is prone to many diseases and in need of regular diagnostic tests, is one of the major drivers for this market. Furthermore, rising prevalence cardiovascular disorders, cancer, diabetes, and other chronic diseases coupled with increasing demand for onsite diagnostics is expected to further propel the in vitro diagnostics (IVD) market.

According to the American Cancer Society (ACS), about 1.7 million new cancer cases are estimated to be reported in 2018 and around 609,640 individuals are likely to die due to cancer in 2018. Most common types of cancer are breast, colorectal, lung, stomach, and liver. Moreover, the number of cancer cases is expected to increase by around 70% over the next two decades. Unhealthy dietary habits, sedentary lifestyle, high tobacco and alcohol consumption, and obesity are the factors expected to contribute to prevalence of cancer.

Growing use of Fluorescence In Situ Hybridization (FISH) and Enzyme Linked Immunosorbent Assay (ELISA) technologies is also anticipated to boost market growth during the forecast period. Continuous research and development activities to introduce enhanced technologies are expected to propel the market. For instance, in November 2017, illumina, Inc., announced the introduction of NextSeq 550Dx instrument, which is expected to deliver high-throughput Next-Generation Sequencing (NGS) to clinical laboratories. The introduction of Xpert assay for tuberculosis testing by Cepheid on its GeneXpert platform is another example of an advancement. Such advancements are anticipated to drive the global IVD market.

Some of the key players in the in vitro diagnostics market are bioMerieux SA; F. Hoffmann-La Roche Ltd.; Becton, Dickinson and Company; Hologic, Inc. (Gen-Probe); Siemens Healthineers, and others. These players are engaged in adopting initiatives such as new product development, collaborations, mergers and acquisition to increase their market share and product portfolio. For instance, in September 2018, Ortho Clinical Diagnostics introduced VITROS Anti-T. cruzi assay with CE mark approval in Mexico. In addition, in June 2017, Ortho Clinical Diagnostics launched VITROS NephroCheck test, a risk assessment tool for predicting Acute Kidney Injury, with CE Mark clearance from European Commission.

Further key findings from the study suggest:

  • Reagent segment held the largest market share of 64.6% in 2017 owing to the presence of wide range of products
  • Molecular diagnostics segment is expected to witness the fastest growth over the forecast period owing to the high usage in detecting various diseases
  • Infectious disease emerged dominant with the market share of USD 14.6 billion in 2017
  • Asia Pacific is expected to exhibit the fastest growth over the forecast period owing to high unmet clinical needs
  • Some of the major players operating in the global in vitro diagnostics (IVD) market include Siemens Healthineers; Becton, Dickinson and Company; bioMerieux SA; Hologic, Inc. (Gen-Probe); and Sysmex Corporation.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMerieux
  • Cepheid
  • Danaher
  • Hologic, Inc. (Gen Probe)
  • Qiagen N.V.
  • MORE
Chapter 1 Research Methodology & Scope
1.1 Information procurement
1.1.1 Purchased database:
1.1.2 Internal database
1.2 Research Methodology
1.3 Geographic Scope & Assumptions
1.4 Country Wise Market Calculation
1.5 Global Market: CAGR Calculation
1.6 Region based segment share calculation
1.7 Primary Sources
1.8 List of Secondary Sources

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Industry Outlook
3.1 Market Segmentation & Scope
3.2 Market Size and Growth Prospects
3.2.1 Market driver analysis
3.2.1.1 Growing geriatric population
3.2.1.2 Increasing prevalence of chronic diseases
3.2.1.3 Introduction of technologically advanced diagnostics
3.2.1.4 Increasing demand for point-of-care diagnostics
3.2.2 Market restraint analysis
3.2.2.1 Stringent regulatory policies
3.2.2.2 High cost of devices
3.2.3 Penetration & growth prospect Mapping
3.2.4 Industry Analysis - Porter’s
3.2.5 Global IVD - PESTEL Analysis

Chapter 4 Market Categorization 1: Product Estimates & Trend Analysis
4.1 Global IVD Market: Product Movement Analysis
4.2 Instruments
4.2.1 Instruments market estimates, 2014 - 2025 (USD Billion)
4.3 Reagents
4.3.1 Reagents market estimates, 2014 - 2025 (USD Billion)
4.4 Services
4.4.1 Services market estimates, 2014 - 2025 (USD Billion)

Chapter 5 Market Categorization 2: Technology Estimates & Trend Analysis
5.1 Global IVD Market: Technology Movement Analysis
5.2 Immunology
5.2.1 Immunology market estimates, 2014 - 2025 (USD Billion)
5.3 Hematology
5.3.1 Hematology market estimates, 2014 - 2025 (USD Billion)
5.4 Clinical Chemistry
5.4.1 Clinical Chemistry market estimates, 2014 - 2025 (USD Billion)
5.5 Molecular Diagnostics
5.5.1 Molecular Diagnostics market estimates, 2014 - 2025 (USD Billion)
5.6 Coagulation
5.6.1 Coagulation market estimates, 2014 - 2025 (USD Billion)
5.7 Microbiology
5.7.1 Microbiology market estimates, 2014 - 2025 (USD Billion)
5.8 Others
5.8.1 Others market estimates, 2014 - 2025 (USD Billion)

Chapter 6 Market Categorization 2: Application Estimates & Trend Analysis
6.1 Global IVD Market: Application Movement Analysis
6.2 Infectious Diseases
6.2.1 Infectious Diseases market estimates, 2014 - 2025 (USD Billion)
6.3 Diabetes
6.3.1 Diabetes market estimates, 2014 - 2025 (USD Billion)
6.4 Oncology/Cancer
6.4.1 Oncology market estimates, 2014 - 2025 (USD Billion)
6.5 Cardiology
6.5.1 Cardiology market estimates, 2014 - 2025 (USD Billion)
6.6 Nephrology
6.6.1 Nephrology market estimates, 2014 - 2025 (USD Billion)
6.7 Autoimmune Diseases
6.7.1 Autoimmune Diseases market estimates, 2014 - 2025 (USD Billion)
6.8 Drug Testing
6.8.1 Drug Testing market estimates, 2014 - 2025 (USD Billion)
6.9 Others
6.9.1 Others market estimates, 2014 - 2025 (USD Billion)

Chapter 7 Market Categorization 4: End-Use Estimates & Trend Analysis
7.1 Global IVD Market: End-Use Movement Analysis
7.2 Hospitals
7.2.1 Hospitals market estimates, 2014 - 2025 (USD Billion)
7.3 Laboratory
7.3.1 Laboratory market estimates, 2014 - 2025 (USD Billion)
7.4 Home Care
7.4.1 Home Care market estimates, 2014 - 2025 (USD Billion)
7.5 Other
7.5.1 Other market estimates, 2014 - 2025 (USD Billion)

Chapter 8 Market Categorization 4: Regional Estimates & Trend Analysis, by Product, Type & End-use
8.1 Global IVD Market: Regional Movement Analysis, 2017 & 2025
8.2 North America
8.2.1 North America IVD market, 2014 - 2025 (USD Billion)
8.2.2 U.S.
8.2.2.1 U.S. IVD Market, 2014 - 2025 (USD Billion)
8.2.3 Canada
8.2.3.1 Canada IVD Market, 2014 - 2025 (USD Billion)
8.2.4 Europe
8.2.5 Europe IVD market, 2014 - 2025 (USD Billion)
8.2.6 Germany
8.2.6.1 Germany IVD market, 2014 - 2025 (USD Billion)
8.2.7 U.K.
8.2.7.1 U.K. IVD market, 2014 - 2025 (USD Billion)
8.3 Asia Pacific
8.3.1 Asia Pacific IVD market, 2014 - 2025 (USD Billion)
8.3.2 Japan
8.3.2.1 Japan IVD market, 2014 - 2025 (USD Billion)
8.3.3 China
8.3.3.1 China IVD market, 2014 - 2025 (USD Billion)
8.4 Latin America
8.4.1 Latin America IVD market, 2014 - 2025 (USD Billion)
8.4.2 Brazil
8.4.2.1 Brazil IVD market, 2014 - 2025 (USD Billion)
8.4.3 Mexico
8.4.3.1 Mexico IVD market, 2014 - 2025 (USD Billion)
8.5 MEA
8.5.1 MEA IVD market, 2014 - 2025 (USD Billion)
8.5.2 South Africa
8.5.2.1 South Africa IVD market, 2014 - 2025 (USD Billion)

Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Heat Map Analysis of Private Companies
9.2.1 Company size
9.2.2 Distribution network
9.2.3 Product portfolio
9.2.4 Segment coverage
9.2.5 Geographic presence
9.2.6 Collaborations
9.2.7 Conclusion
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic Initiatives
9.4 bioMerieux
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Abbott Laboratories
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Sysmex Corporation
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Ortho Clinical Diagnostics
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 Danaher
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Hologic, Inc. (Gen Probe)
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 Cepheid
9.10.1 Company Overview
9.10.2 Product Benchmarking
9.10.3 Strategic Initiatives
9.10.4 F. Hoffmann-La Roche Ltd
9.10.5 Company Overview
9.10.6 Financial Performance
9.10.7 Product Benchmarking
9.10.8 Strategic Initiatives
9.11 Siemens Healthineers
9.11.1 Company Overview
9.11.2 Financial Performance
9.11.3 Product Benchmarking
9.11.4 Strategic Initiatives
9.12 Stago
9.12.1 Company Overview
9.12.2 Product Benchmarking
9.12.3 Strategic Initiatives
9.13 Instrumentation Laboratory
9.13.1 Company Overview
9.13.2 Financial Overview
9.13.3 Product Benchmarking
9.13.4 Strategic Initiatives
9.14 Leica Biosystems Nussloch Gmbh
9.14.1 Company Overview
9.14.2 Product Benchmarking
9.14.3 Strategic Initiatives
9.15 Bio-Rad Laboratories, Inc.
9.15.1 Company Overview
9.15.2 Financial Performance
9.15.3 Product Benchmarking
9.15.4 Strategic Initiatives
9.16 Quidel Corporation
9.16.1 Company Overview
9.16.2 Financial Performance
9.16.3 Products Benchmarking
9.16.4 Strategic Initiatives
9.17 Qiagen N.V.
9.17.1 Company Overview
9.17.2 Financial Performance
9.17.3 Product Benchmarking
9.17.4 Strategic Initiatives
9.18 OraSure Technologies, Inc.
9.18.1 Company Overview
9.18.2 Financial Performance
9.18.3 Products Benchmarking
9.18.4 Strategic Initiatives

List of Tables
Table 1 North America IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 2 North America IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 3 North America IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 4 North America IVD Market, by End-use, 2014 - 2025 (USD Billion)
Table 5 U.S. IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 6 U.S. IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 7 U.S. IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 8 U.S. IVD Market, by End-use, 2014 - 2025 (USD Billion)
Table 9 Canada IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 10 Canada IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 11 Canada IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 12 Canada IVD Market, by End-use, 2014 - 2025 (USD Billion)
Table 13 Europe IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 14 Europe IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 15 Europe IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 16 Europe IVD Market, by End-use2014 - 2025 (USD Billion)
Table 17 UK IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 18 UK IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 19 UK IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 20 UK IVD Market, by End-use, 2014 - 2025 (USD Billion)
Table 21 Germany IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 22 Germany IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 23 Germany IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 24 Germany IVD Market, by End-use, 2014 - 2025 (USD Billion)
Table 25 Asia Pacific IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 26 Asia Pacific IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 27 Asia Pacific IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 28 Asia Pacific IVD Market, by End-use, 2014 - 2025 (USD Billion)
Table 29 Japan IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 30 Japan IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 31 Japan IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 32 Japan IVD Market, by End-use, 2014 - 2025 (USD Billion)
Table 33 China IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 34 China IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 35 China IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 36 China IVD Market, by End-use, 2014 - 2025 (USD Billion)
Table 37 Latin America IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 38 Latin America IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 39 Latin America IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 40 Latin America IVD Market, by End-use, 2014 - 2025 (USD Billion)
Table 41 Brazil IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 42 Brazil IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 43 Brazil IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 44 Brazil IVD Market, by End-use, 2014 - 2025 (USD Billion)
Table 45 Mexico IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 46 Mexico IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 47 Mexico IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 48 Mexico IVD Market, by End-use, 2014 - 2025 (USD Billion)
Table 49 MEA IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 50 MEA IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 51 MEA IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 52 MEA IVD Market, by End-use, 2014 - 2025 (USD Billion)
Table 53 South Africa IVD Market, by Product, 2014 - 2025 (USD Billion)
Table 54 South Africa IVD Market, by Technique, 2014 - 2025 (USD Billion)
Table 55 South Africa IVD Market, by Application, 2014 - 2025 (USD Billion)
Table 56 South Africa IVD Market, by End-use, 2014 - 2025 (USD Billion)

List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Market summary
FIG. 4 Market segmentation & scope
FIG. 5 Market size and growth prospects
FIG. 6 Global IVD - Key market driver analysis
FIG. 7 Global IVD market - Key market restraint analysis
FIG. 8 Penetration & growth prospect mapping
FIG. 9 Global IVD market - Porter’s analysis
FIG. 10 Global IVD market f PESTEL analysis
FIG. 11 Global IVD market product outlook key takeaways
FIG. 12 Global IVD market: Product movement analysis
FIG. 13 Instruments market estimates, 2014 - 2025 (USD Billion)
FIG. 14 Reagents market estimates, 2014 - 2025 (USD Billion)
FIG. 15 Services market estimates, 2014 - 2025 (USD Billion)
FIG. 16 Global IVD market technology outlook key takeaways
FIG. 17 Global IVD market: Technology movement analysis
FIG. 18 Immunology market estimates, 2014 - 2025 (USD Billion)
FIG. 19 Hematology market estimates, 2014 - 2025 (USD Billion)
FIG. 20 Clinical Chemistry market estimates, 2014 - 2025 (USD Billion)
FIG. 21 Molecular Diagnostics market estimates, 2014 - 2025 (USD Billion)
FIG. 22 Coagulation market estimates, 2014 - 2025 (USD Billion)
FIG. 23 Microbiology market estimates, 2014 - 2025 (USD Billion)
FIG. 24 Others market estimates, 2014 - 2025 (USD Billion)
FIG. 25 Global IVD market application outlook key takeaways
FIG. 26 Global IVD market: Application movement analysis
FIG. 27 Infectious Diseases market estimates, 2014 - 2025 (USD Billion)
FIG. 28 Diabetes market estimates, 2014 - 2025 (USD Billion)
FIG. 29 Oncology market estimates, 2014 - 2025 (USD Billion)
FIG. 30 Cardiology market estimates, 2014 - 2025 (USD Billion)
FIG. 31 Nephrology market estimates, 2014 - 2025 (USD Billion)
FIG. 32 Autoimmune Diseases market estimates, 2014 - 2025 (USD Billion)
FIG. 33 Drug Testing market estimates, 2014 - 2025 (USD Billion)
FIG. 34 Others market estimates, 2014 - 2025 (USD Billion)
FIG. 35 Global IVD market end-use outlook key takeaways
FIG. 36 Global IVD market: End-use movement analysis
FIG. 37 Hospitals market estimates, 2014 - 2025 (USD Billion)
FIG. 38 Laboratory market estimates, 2014 - 2025 (USD Billion)
FIG. 39 Home Care market estimates, 2014 - 2025 (USD Billion)
FIG. 40 Other market estimates, 2014 - 2025 (USD Billion)
FIG. 41 Regional market place: Key takeaways
FIG. 42 Global IVD market: Regional movement analysis
FIG. 43 North America IVD market, 2014 - 2025 (USD Billion)
FIG. 44 U.S. IVD Market, 2014 - 2025 (USD Billion)
FIG. 45 Canada IVD Market, 2014 - 2025 (USD Billion)
FIG. 46 Europe IVD market, 2014 - 2025 (USD Billion)
FIG. 47 Germany IVD market, 2014 - 2025 (USD Billion)
FIG. 48 UK IVD market, 2014 - 2025 (USD Billion)
FIG. 49 Asia Pacific IVD market, 2014 - 2025 (USD Billion)
FIG. 50 Japan IVD market, 2014 - 2025 (USD Billion)
FIG. 51 China IVD market, 2014 - 2025 (USD Billion)
FIG. 52 Latin America IVD market, 2014 - 2025 (USD Billion)
FIG. 53 Brazil IVD market, 2014 - 2025 (USD Billion)
FIG. 54 Mexico IVD market, 2014 - 2025 (USD Billion)
FIG. 55 MEA IVD market, 2014 - 2025 (USD Billion)
FIG. 56 South Africa IVD market, 2014 - 2025 (USD Billion)
FIG. 57 Strategy framework
FIG. 58 Heat map analysis
FIG. 59 Becton, Dickinson and Company overview
FIG. 60 .bioMerieux overview
FIG. 61 Abbott Laboratories, Inc. overview
FIG. 62 Sysmex Corporation overview
FIG. 63 Ortho Clinical Diagnostics overview
FIG. 64 Danaher overview
FIG. 65 Hologic, Inc. overview
FIG. 66 Cepheid overview
FIG. 67 F. Hoffmann-La Roche Ltd overview
FIG. 68 Siemens Healthineers overview
FIG. 69 Stago overview
FIG. 70 Instrumentation Laboratory overview
FIG. 71 Leica Biosystems Nussloch Gmbh overview
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Becton, Dickinson and Company
  • bioMerieux
  • Abbott Laboratories
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Danaher
  • Hologic, Inc. (Gen Probe)
  • Cepheid
  • Siemens Healthineers
  • Stago
  • Instrumentation Laboratory
  • Leica Biosystems Nussloch Gmbh
  • Bio-Rad Laboratories, Inc.
  • Quidel Corporation
  • Qiagen N.V.
  • OraSure Technologies, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll